Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers
A Randomized Controlled Trial of Enzymatic Debridement of Pressure Ulcers With Clostridial Collagenase Ointment (SANTYL®) or Hydrogel (SoloSite®)
Sponsor: Smith & Nephew, Inc.
Terminated
Business Decision
Other terminated trials from Smith & Nephew, Inc.
- Acute Wounds · Oct 2025
- Meniscus Tear · Apr 2024
- Arthroplasty · Mar 2024
- Avascular Necrosis · Phase NA · Feb 2024
- Osteoarthritis of the Shoulder · Dec 2023
More terminations from Smith & Nephew, Inc.
A PHASE4 clinical study on Pressure Ulcer, this trial is terminated or withdrawn. The trial is conducted by Smith & Nephew, Inc. and has accumulated 10 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Mar 2022 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2022 — Mar 2022 [monthly]
Terminated PHASE4
-
Dec 2021 — Jan 2022 [monthly]
Terminated PHASE4
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
Apr 2020 — Jan 2021 [monthly]
Terminated PHASE4
-
Jun 2018 — Apr 2020 [monthly]
Terminated PHASE4
-
Apr 2017 — Jun 2018 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Jan 2017 — Apr 2017 [monthly]
Recruiting PHASE4
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Smith & Nephew, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .